Journal article
Familial British Dementia: Expression and Metabolism of BRI
Annals of the New York Academy of Sciences, Vol.920(1), pp.93-99
12/2000
DOI: 10.1111/j.1749-6632.2000.tb06909.x
PMID: 11193182
Abstract
Vidal et al. (1999. Nature 399: 776-778) discovered that the underlying genetic lesion in familial British dementia (FBD) is a T-A transversion at the termination codon of a membrane protein, termed BRI. The mutation creates an arginine codon; translational read-through generates a novel protein, termed BRI-L, that is extended by 11 amino acids at the carboxyl-terminus. BRI-L is the precursor of the ABri peptide, a component of amyloid deposits in FBD brain. We demonstrate that both BRI and its mutant counterpart are constitutively processed by furin, resulting in the secretion of carboxyl-terminal peptide derivatives that correspond to all, or part of, ABri. Notably, elevated levels of peptides are generated from the mutant BRI precursor, suggesting that subtle conformational alterations at the carboxyl-terminus may influence furin-mediated processing. We have examined BRI/BRI-L processing by other members of the prohormone convertase (PC) family (PACE4, LPC, PC 5/6) and found that these enzymes also process BRI, albeit inefficiently. Moreover, BRI-L processing by the other PC members is severely compromised. Finally, our electron microscopic studies reveal that synthetic ABri peptides assemble into insoluble beta-pleated fibrils. Collectively, our results support the view that enhanced furin-mediated processing of mutant BRI generates amyloidogenic peptides that initiate the pathogenesis of FBD.
Details
- Title: Subtitle
- Familial British Dementia: Expression and Metabolism of BRI
- Creators
- SEONG-HUN KIM - Department of Neurobiology, Pharmacology and Physiology, University of Chicago, Chicago, Illinois, USARONG WANG - Laboratory of Mass Spectrometry, Rockefeller University, New York, New York 10021, USADAVID J GORDON - Medical Scientists Training Program and Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, USAJOSEPH BASS - Howard Hughes Medical Institute, University of Chicago, Chicago, Illinois, USADONALD F STEINER - Howard Hughes Medical Institute, University of Chicago, Chicago, Illinois, USAGOPAL THINAKARAN - Department of Neurobiology, Pharmacology and Physiology, University of Chicago, Chicago, Illinois, USADAVID G LYNN - Department of Pathology, University of Chicago, Chicago, Illinois 60637, USASTEPHEN C MEREDITH - Department of Pathology, University of Chicago, Chicago, Illinois 60637, USASANGRAM S SISODIA - Department of Neurobiology, Pharmacology and Physiology, University of Chicago, Chicago, Illinois, USA
- Resource Type
- Journal article
- Publication Details
- Annals of the New York Academy of Sciences, Vol.920(1), pp.93-99
- DOI
- 10.1111/j.1749-6632.2000.tb06909.x
- PMID
- 11193182
- NLM abbreviation
- Ann N Y Acad Sci
- ISSN
- 0077-8923
- eISSN
- 1749-6632
- Publisher
- Blackwell Publishing Ltd
- Number of pages
- 7
- Language
- English
- Date published
- 12/2000
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984093317802771
Metrics
13 Record Views